110 related articles for article (PubMed ID: 18779485)
1. Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes.
Cohen VM; Shields CL; Demirci H; Shields JA
Arch Ophthalmol; 2008 Sep; 126(9):1245-51. PubMed ID: 18779485
[TBL] [Abstract][Full Text] [Related]
2. Management of retinal vasoproliferative tumor associated with ROP by plaque brachytherapy.
Kitei PM; Say EA; Shields CL; Regillo CD; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Feb; 48 Online():e10-2. PubMed ID: 21323303
[TBL] [Abstract][Full Text] [Related]
3. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
4. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma.
Kreusel KM; Bornfeld N; Lommatzsch A; Wessing A; Foerster MH
Ophthalmology; 1998 Aug; 105(8):1386-92. PubMed ID: 9709747
[TBL] [Abstract][Full Text] [Related]
6. Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Shukla SY; Reilly B; Shields JA
JAMA Ophthalmol; 2013 Mar; 131(3):328-34. PubMed ID: 23494037
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants.
Walinjkar JA; Sharma US; Rishi P; Rishi E; Gopal L; Sharma T
Indian J Ophthalmol; 2018 Feb; 66(2):246-251. PubMed ID: 29380768
[TBL] [Abstract][Full Text] [Related]
8. Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases.
Manjandavida FP; Shields CL; Kaliki S; Shields JA
Retina; 2014 Aug; 34(8):1644-50. PubMed ID: 24752009
[TBL] [Abstract][Full Text] [Related]
9. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
10. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
[TBL] [Abstract][Full Text] [Related]
11. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.
Kubicka-Trząska A; Karska-Basta I; Oleksy P; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2015-9. PubMed ID: 26004077
[TBL] [Abstract][Full Text] [Related]
12. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
13. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
Kivelä T; Puusaari I; Damato B
Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.
Anastassiou G; Bornfeld N; Schueler AO; Schilling H; Weber S; Fluehs D; Jurklies B; Vij O; Sauerwein W
Br J Ophthalmol; 2006 Apr; 90(4):447-50. PubMed ID: 16547325
[TBL] [Abstract][Full Text] [Related]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
16. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
17. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.
Krivosic V; Massin P; Desjardins L; Le Hoang P; Tadayoni R; Gaudric A
Am J Ophthalmol; 2014 Jul; 158(1):154-161.e1. PubMed ID: 24631475
[TBL] [Abstract][Full Text] [Related]
18. IODINE-125 PLAQUE BRACHYTHERAPY FOR DIFFUSE CHOROIDAL HEMANGIOMA.
Azarcon CP; Qiu RLJ; Sobol EK; Hubbard GB; Craven CM; Bergstrom CS; Wells JR
Retin Cases Brief Rep; 2024 Jan; 18(1):51-58. PubMed ID: 36007192
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
20. High-dose iodine-125 episcleral brachytherapy for circumscribed choroidal haemangioma.
López-Caballero C; Saornil MA; De Frutos J; Bianciotto C; Muiños Y; Almaraz A; López-Lara F; Contreras I
Br J Ophthalmol; 2010 Apr; 94(4):470-3. PubMed ID: 19822913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
